Dr. Alison J. Schneider, MD

Dr. Schneider practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Schneider's NPI, 1144424607, was assigned on June 11, 2007. Dr. Schneider graduated from University of Miami, Miller School of Medicine in 2001. Dr. Schneider holds Florida license ME97980.

Dr. Schneider's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Schneider's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Schneider is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Schneider to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schneider practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Schneider's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Schneider is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Schneider's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Schneider treats.

CMS data shows 991 Medicare services from Dr. Schneider across 17 procedure codes in 2024, for 477 Medicare patients. Medicare paid $75,386 for them.

CMS counts 477 Medicare patients who saw Dr. Schneider in 2024. The largest group is 65 to 74, with 248 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schneider's median patient age at 62, with 67% women.

In 2024, Dr. Schneider wrote 1,302 Medicare Part D claims for 352 patients. 76% of them were for generic drugs. CMS names the drug for 1,088 of them, across 30 drugs with 11 or more claims each, at $514,916 in total drug cost. In 2023, CMS named 1,242 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Schneider for performance year 2024, reported through an alternative payment model (APM). Dr. Schneider accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schneider as offering telehealth. CMS counts 93 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Schneider, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Schneider, published from 2009 to 2023. 2020 was the busiest year, with 3. The most frequent topics are Colonoscopy, Colonic Polyps and Colorectal Neoplasms. Dr. Schneider has published most often in ACG Case Rep J. Dr. Schneider's most frequent co-authors are Tolga Erim, DO, Adalberto Jose Gonzalez, MD and Ronnie R. Pimentel, MD.

Dmand AI links Dr. Schneider to 3 clinical trials. Conditions studied include Clostridium Infections, Gastroparesis and Diarrhea.

CMS Open Payments shows 276 general payments to Dr. Schneider from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Allergan Inc. paid the most, $25,365.

Dmand AI lists 2 awards for Dr. Schneider, most recently CMS Stage 1 EHR in 2013.

Dr. Schneider graduated from University of Miami, Miller School of Medicine in 2001. Dr. Schneider is a member of ACG, AGA, AMA and ASGE.

Dr. Schneider is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.